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Abstract. Invariant (Ii) chain is a membrane-spanning 
protein that is found associated intracellularly with 
class II histocompatibility antigens. 
In the endoplasmic reticulum Ii chain spans the 
membrane and exposes the NH2 terminus on the cy- 
toplasmic and the COOH terminus on the lumenal 
side. This orientation across the membrane is demon- 
strated irectly with the monoclonal antibody In-l, 
which exclusively recognizes the NH2 terminal cyto- 
plasmically exposed part of Ii chain. 
Membrane insertion of Ii chain requires ignal rec- 
ognition particle and docking protein. When tested in 
a wheat germ cell free system, signal recognition parti- 
cle arrests translation of Ii chain. No signal sequence 
is cleaved from Ii chain upon membrane insertion. 
~ ECRETORY and many membrane-spanning proteins are translocated across or inserted into the membrane of 
the endoplasmic reticulum (ER) ~ in a co-translational 
manner (for review see references 3, 21, 35, 50, and 51). 
Translocation requires a signal sequence on the nascent poly- 
peptide chain and specific receptors, the signal recognition 
particle (SRP) and the docking protein (DP) or SRP receptor 
(1, 2, 6, 18, 19, 32, 33, 38, 46-49). SRP has been shown to 
interact with polysomes holding nascent preprolactin hains, 
and it has been proposed that SRP binds to the signal sequence 
(46). When probed in a wheat germ cell free system with 
prolactin or IgG light chain mRNAs, SRP arrests the peptide 
elongation after 70-80 amino acids have been polymerized 
(33, 47, 48). Elongation proceeds after SRP has bound to the 
DP, which is located in the ER membranes (18, 19, 33). 
Cleavable signal sequences have also been found on pro- 
teins that span the membrane once and expose the carboxy 
(COOH) terminus on the cytoplasmic and the amino (NH2) 
terminus on the extracytoplasmic side of the membrane. 
Examples of these types of proteins, which we call here type 
I membrane proteins, are the G protein of vesicular stomatitis 
virus (24, 30, 37) and class I and II histocompatibility antigens 
(12, 29). The PE2 glycoproteins of Semliki Forest virus and 
Sindbis virus seem to have an uncleaved signal sequence (5, 
i 6, 17). For the PE2 protein of Sindbis virus, an SRP-mediated 
membrane insertion has been found (5). Translocation ofthe 
NH2-terminal portion of type I membrane proteins is thought 
to proceed in a manner identical to that of secretory proteins 
1. Abbreviations used in this paper." Con A, coneanavalin A; DP, docking 
protein; ER, endoplasmic reticulum; li, invariant; SRP, signal recognition 
particle; TCA, trichloroacetic a id. 
(21, 35, 51). They become, however, arrested in the mem- 
brane by a hydrophobic stop transfer sequence, which is 
usually located close to the NH2-terminal end of the protein 
(4, 13, 51). 
No cleavable signal sequence has generally been found on 
proteins that span the membrane once and expose the NH2 
terminus on the cytoplasmic and the COOH terminus on the 
extracytoplasmic s de. Among the investigated proteins are 
the influenza neuraminidase (8, 15), the rat and human 
asialoglycoprotein receptor (9, 20, 41), and the human trans- 
ferrin receptor (39). These proteins we call type II membrane 
proteins. We are interested in the question of how these 
proteins become integrated into the membrane. 
Invariant (li) chain (also called l-r-chain) is thought to be a 
type II membrane-spanning glycoprotein (13, 31). It is found 
intracellularly assembled with mouse Ia and human HLA- 
DR (class II) histocompatibility antigens (23, 25, 27, 34, 43). 
Assembly of li chain with class II antigens occurs already in 
the ER (27, 43). During the intracellular t ansport, he oligo- 
meric complex disassembles and only class II antigens appear 
on the cell surface, li chain seems to remain in a yet uniden- 
tified intracellular compartment (27, 43). 
The complete sequences ofhuman and mouse Ii chain have 
been determined (11, 31, 40, 42). DNA sequence analysis 
shows that Ii chain contains a single stretch of hydrophobic 
amino acids, and this is located between residues 31 and 56. 
Based on this finding, it has been proposed that Ii chain spans 
the membrane close to the NH2 terminus and exposes the 
NH2 terminus on the cytoplasmic side of the membrane (11, 
40, 42). Here we provide direct experimental evidence that 
the mouse li chain exposes its NH2 terminus on the cyto- 
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plasmic side of ER membranes and that Ii chain is inserted 
into the membrane in an SRP-dependent manner. 
Materials and Methods 
Materials 
Concanavalin A (Con A)-Sepharose and protein A-Sepharose were obtained 
from Pharmacia, Uppsala, Sweden; guanidinium-hydrochloride was from Be- 
thesda Research Laboratories, Bethesda, MD; [3SS]methionine and ENHANCE 
were from New England Nuclear, Boston, MA; 7-methyl-guanosine-5'-mono- 
phosphate and phenylmethylsulfonyl fluoride were from Sigma, Mtinchen, 
FRG.; oligo (dT)-cellulose (type II) was from Collaborative Research, Inc., 
Waltham, MA; proteinase K was from Merck, Darmstadt, FRG.; RPMI 1640 
was from Gibco, Bio-Cult Ltd., Paisley, Scotland; Staphylococcus aureus V8 
protease was from Miles GmbH, Frankfurt, FRG.; tunicamycin was from 
Calbiochem, Giessen, FRG. 
Monoclonal antibody In-l has been described previously (26) and was a 
generous gift from Giinther H~immerling. 
Methods 
mRNA Purification and Size Fractionation. Total mRNA was isolated from 
the spleens of SL2 mice by a modified guanidinium hydrochloride method 
(10). Approximately 20 g of frozen spleens were homogenized in 200 ml 6 M 
guanidinium HCI/1 mM dithiothreitol/20 mM NaAc pH 7.0 (buffer I), using 
a Sorvall Omni-mixer at full speed for pulses of 30-s each. The homogenate 
was centrifuged for 5 rain at 5,000 g at 4"C. The resulting supernatant was 
adjusted to pH 5.0 with 4 N acetic acid and the RNA was precipitated by 
adding half a volume of ice-cold ethanol. Insoluble material was collected by 
centrifugation and dissolved in 100 ml of buffer 1, adjusted to pH 5, and 
reprecipitated asabove. After centrifugation, the pellet was dissolved in 10 ml 
50 mM Tris/HCl, pH 7.5, 120 mM NaCl, 5 mM EDTA, 1% SDS (buffer 2), 
and extracted twice with phenol/chloroform. Poly (A) + RNA was obtained by 
affinity chromatography on an oligo(dT)-cellulose column, mRNA was size 
fractionated by sucrose gradient centrifugation. Fractions enriched in mRNA 
that code for Ii chain were identified by cell free translation (see below) and 
immunoprecipitation (12). 
Cell Free Protein Synthesis. Total or size fractionated mRNA was translated 
in a wheat germ cell free system (36). The system was supplemented with either 
2 A2~o U/ml of dog pancreas microsomes, pretreated with micrococcal nuclease 
and high salt, and/or 0.1 A2ao/ml of gradient-fractionated SRP (48). Micro- 
sprees were prepared and treated as described previously (16, 32). SRP was 
prepared essentially as described (48) with the exception that Nikkol was 
omitted in the fractionation on DEAE Sepharose and in the sucrose gradients. 
Except when otherwise stated, cell free translation was done at 25"C. Proteins 
were analyzed by SDS PAGE (28) and bands were visualized by fiuorography 
(7) using ENHANCE. 
Cell Culture and Labeling of Cells. B-lymphoma cells (CH I. l.) were cultured 
in RPM1 1640 medium containing 8% fetal calf serum, l0 U penicillin/ 
streptomycin, 10 #M mereaptocthanol. Cells were washed twice in methionine- 
free medium and incubated for 20 min at 37"C in the same medium. [3sS] 
Methionine was added to a final concentration of 400 #Ci/ml, and the cells 
were incubated at 37*(2 for 60 min. Cells were washed and then solubilized in 
ice-cold 50 mM Tris-HC1 buffer (pH 7.5) containing 0.15 M NaCl, 5 mM 
MgCl~, 1% Triton X-100. Protease inhibitor phenylmethylsulfonyl fluoride was 
added to a final concentration of 20 ~g/ml. Debris were removed by centrif- 
ugation at 4"C for 15 rain in a microfuge, and the supernatant was used for 
immunoprecipitation a d SDS PAGE. In some experiments glycosylation of 
asparagine residues was blocked by adding tunicamycin to the cell culture 
medium to a final concentration of 3 ug/ml. After incubation for 150 rain at 
37°C, cells were labeled as described above. 
Protease Treatments. A lysate (0.5 ml) derived from 2 x l06 CHl.l. cells 
was treated with different amounts (5-50 ~g) of Staphylococcus aureus V8 
protease for 15 min at 30"C. Proteolysis was stopped by addition of trichlore- 
acetic acid (TCA) to a final concentration of 10%. The TCA precipitate was 
washed twice with 10% TCA/50% acetone to remove the detergent and 
solubilized in 25/~l of sample buffer containing 3% SDS (3). After SDS PAGE, 
the proteins were transferred onto nitrocellulose filters (44). 
In vitro synthesized proteins were digested with protease by adding 1 vol of 
2% Triton X-100, 100 mM Tris HCI, oH 7.5, 300 mM NaCI, and Staphylo- 
coccus aureus V8 protease to a final concentration of 50 #g/ml and incubating 
the sample for 15 rain at 30"C. Proteolysis was stopped by addition of phenyl- 
methylsulfonyl fluoride (20 #g/ml). For proteolysis of immunoadsorbed li 
chain, In-1 antibody and protein A-Sepharose were added to either a CH 1.1. 
cell lysate or a cell free lysate (12). The mixture was incubated for 60 rain and 
the Sepharose beads with bound IgG and Ii chains washed and resuspended in 
20 #1 of l0 mM Tris-Ha pH 7.5 and 50 ~g/ml of Staphylococcus aureus V8 
protease. After incubation for 15 rain at 30"C, protein fragments were imme- 
diately analyzed by SDS PAGE. 
lmmunoblotting. Proteins were electrophoretically transferred from SDS 
polyacrylamide gels onto a nitrocellulose filter (44). The nitrocellulose filter 
was washed twice for 20 rain in phosphate-buffered saline (PBS) containing 
10% newborn calf serum, then treated for 90 min with cell culture supernatant 
containing In-1 antibody, washed 4x in PBS/newborn calf serum and once in 
PBS/newborn calf serum containing 0.05% Triton X-100. Bound antibody was 
detected with rabbit anti-rat lgG coupled to horseradish peroxidase and stained 
with diaminobenzidine (44). 
Binding of Proteins to Con A-Sepharose. After translation of spleen cell 
mRNA in a 25-~1 wheat germ cell free system in the presence of rough 
microsomes, membranes were pelleted by centrifugation for 20 rain at 10,000 
rpm at 4"C, They were then solubilized in 0.5% Triton X-100, 150 mM NaCI, 
50 mM Tris-HCl, pH 7.5, 1 mM CaCI2, 1 mM MnCI2, and 4 ug/ml of 
phenylmethylsulfonyl fluoride and then 50 #1 of Con A-Sepharose was added 
(a slurry containing beads to solubilization buffer in a 1 : 1 ratio). The mixture 
was incubated for 60 min at room temperature. Beads were then washed three 
times with 100 mM acetate at pH 6, 150 mM NaCI, 1 raM MnC1, 1 mM 
CaCI2, and 1 mM MgCI2. To the pelleted beads ample buffer for SDS PAGE 
was added and proteins analyzed as described (28). 
Results 
To characterize the disposition of Ii chain across the mem- 
brane of the ER, we translated mRNA from mouse spleen 
cells in a wheat germ cell free system in the presence of 
microsomal membranes derived from dog pancreas. In such 
a system membrane proteins become inserted into the mem- 
brane asymmetrically in the same way as in the cell and the 
orientation across the membrane can be determined by pro- 
tease treatment (24, 37). Protease will cleave only that part of 
a membrane protein that is exposed on the cytoplasmic side, 
whereas the lumenally disposed part is protected by the mem- 
brane. The orientation of the protein across the membrane 
can then be deduced, if the means exist for detecting the 
COOH or NH2 termini of the protein. Since we could make 
use of a monoclonal antibody specific for Ii chain, we tested 
whether the antibody recognizes exclusively either the lumen- 
ally or the cytoplasmically disposed portion of Ii chain. De- 
pending on the location of the antigenic determinant of In- 1 
we would be able to discriminate between the two possible 
orientations of Ii chain across the membrane. 
Mouse li Chain Spans the Membrane 
When spleen mRNA is translated in the wheat germ cell free 
system and labeled proteins are immunoprecipitated with 
monoclonal In-1 antibody, a 25-kD form of Ii chain is selected 
(Ii') (Fig. !, lane I). When translation is performed in the 
presence of microsomal membranes, a 3 l-kD protein is syn- 
thesized and this has the same molecular weight as the au- 
thentic Ii chain synthesized in vivo (Fig. 1, lane 2). The latter 
form is glycosylated, whereas the former is not (see below). 
Both forms have been described previously (40). Due to the 
binding to protein A or Con A, the heavy chains of IgG are 
also precipitated (Fig. 1, lanes 1, 2, 3, 5, and 6). IgG is a 
typical secretory protein that is translocated across micro- 
spinal membranes and therefore can be used to assess the 
intactness of the microsomal membranes. After digestion with 
proteinase K no Ii chain-related protein can be precipitated 
with In-1 antibody (Fig. 1, lane 3). Heavy chain of IgG, 
The Journal of Cell Biology, Volume 102, 1986 2170 
 o
n
 January 9, 2006 
w
w
w
.jcb.org
D
ow
nloaded from
 
Figure 1. Protease digestion of Ii chain from intact and detergent- 
solubilized microsomal vesicles, mRNA from mouse spleen cells was 
translated in a wheat germ cell free system in the absence (lane 1) or 
presence of dog pancreas microsomal membranes (lanes 2-7). After 
translation, proteinase K, 0.5 mg/ml final concentration (lanes 3 and 
6), or proteinase K and 0.5% Triton X-100 (lanes 4 and 7) were 
added and the mixture incubated for 15 min at 30°C. Ii chain was 
immunoprecipitated using In-i antibody and protein A-Sepharose 
(lanes 1-4). Glycoproteins were isolated by binding to Con A- 
Sepharose (lanes 5-7). Antigens were separated by SDS PAGE and 
visualized by fluorography. Ii, membrane inserted and glycosylated 
invariant chain, li', unglycosylated form of Ii chain. H, heavy chain 
of IgG that binds to protein A-Sepharose and Con A-Sepharose. 
however, is readily precipitable, demonstrating that a protec- 
tion against protease digestion has been obtained for proteins 
located in the lumen of microsomal vesicles. When Triton X- 
100 is used together with proteinase K, the lumenally located 
heavy chain of IgG is digested, indicating that protection is 
dependent on the intact membrane barrier (Fig. l, lanes 4 
and 7). 
The inability for In-1 antibody to precipitate Ii chain after 
protease digestion of intact microsomes could indicate that 
the antibody recognizes the part of the polypeptide chain that 
is exposed on the cytoplasmic side of the membrane. To 
detect processed Ii chain, we used Con A-Sepharose. Ii chain 
is known to be glycosylated and should therefore bind to Con 
A (43). It furthermore is the major 35S-labeled glycoprotein 
synthesized by spleen cells and should therefore be readily 
detectable among the spleen cell glycoproteins. Fig. 1, lane 6 
shows that this is indeed the case and that proteinase K 
treatment of microsomal vesicles reduces the size of Ii chain 
by ~3 kD. This reduction in size indicates that mouse Ii 
chain, as its human counterpart, spans the membrane and 
exposes ~30 amino acid residues on the cytoplasmic side of 
the membrane. This result also demonstrates that the cyto- 
plasmic portion is essential for the recognition f Ii chain by 
In-1 antibody. 
ln - I  Ant ibody Recognizes the NH2-Termina l  Portion 
o f  I i  Chain 
To determine the recognition site for In- 1 on Ii chain, proteo- 
lytic fragments of Ii chain were generated using Staphylococ- 
cus aureus V8 protease. 
Mouse CH 1.1. cells, which express relatively large amounts 
of Ii chain, were labeled for 1 h with [3SS]methionine and Ii 
chains were precipitated with In-1 antibody. Immunoprecip- 
itated polypeptides were characterized by SDS PAGE, either 
directly (Fig. 2, lanes 1 and 4) or after treatment with 5 ug/ 
ml (Fig. 2, lane 2) or 50 ug/ml (Fig. 2, lane 3) 78 protease. 
As expected, Ii chain and a 41-kD protein were precipitated 
with the In-1 antibody (26, 52, 53). The 41-kD protein is an 
Ii gene product generated most likely by differential splicing 
(52). With increasing concentrations of the V8 protease, Ii
chain was digested into three major polypeptides, labeled A, 
B, and C (Fig. 2). Polypeptide A has a molecular weight of 
~29 kD, B o f~20 kD, and C of ~10 kD. It appears that the 
cleavage of A generates fragments B and C adding up to the 
molecular weight of 29 kD. 
To obtain information about the location of the three 
proteolytic fragments in the linear structure of the Ii chain, 
the same digestion was performed on [35S]cysteine-labeled Ii 
chain. A single cysteine residue is known to occur in Ii chains 
and this residue is located in the NHz-terminal portion (11, 
31, 42). Fig. 2, lanes 5-7 shows the results obtained with [35S] 
cysteine-labeled Ii chains before (lane 5) or after the digestion 
with 5 ug/ml (lane 6) or 50 ug/ml (lane 7) of V8 protease. Ii
chain and the fragments A and C are radioactively labeled 
with cysteine, but not fragment B. Thus, Staphylococcus 
aureus V8 protease cuts the Ii chain essentially twice giving 
rise to three polypeptides labeled A, B, and C in Fig. 2. 
To demonstrate the location of the fragment C within the 
polypeptide chain directly, we introduced a gradient of label 
into Ii chain, mRNA from spleen cells was translated in the 
presence of microsomal membranes. 1 min after the start of 
translation, 7-methyl-guanosine was added to synchronize 
mRNA translation. After different time intervals (Fig. 3), 
unlabeled methionine was added to a final concentration of 
Figure 2. Digestion of Ii chain with Staphylococcus aureus V8 pro- 
tease. Mouse CHI.I. cells were labeled for 1 h with either [35S]- 
methionine (lanes 1-4) or [35S]cysteine (lanes 5-7). Ii antigens were 
immunoprecipitated an  incubated with no proteas¢ (lanes 1, 4, and 
5) or with 5 t~g/ml (lanes 2 and6) or 50 ~g/ml V8 protease (lanes 3 
and 7) for 15 rain at 30"C. The positions ofglycosylated Ii chain, the 
41-kD polypeptide, and fragments A, B, and C which are generated 
upon cleavage with Staphylococcus aureus V8 protease are indicated, 
Lipp and Dobberstein Membrane Junction of li Chain 2171 
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Figure 3. Pulse labeling of Ii chain and its fragments generated by 
Staphylococcus aureus V8 protease digestion, mRNA from mouse 
spleen cells was translated in a wheat germ cell free system in the 
presence of dog pancreas microsomes with [35S]methionine as label. 
To synchronize translation 7-methyl-guanosine-5'-monophosphate 
was added after 1 min. Different lengths of pulse were achieved by 
adding unlabeled methionine at the times indicated in the figure. 
Antigens were immunoprecipitated as d scribed, digested with 10 ~g/ 
ml V8 protease for 15 rain at 30"C, and characterized by SDS PAGE 
and fluorography. Radioactivity n bands A (O), B (O), and C (x) (see 
Fig. 2) was quantitated by densitometry. The constant amount of 
label in peptide C indicates thatit is localized close to the NH2- 
terminal end. Two scales were used because of different amounts of 
label in the fragments A, B and C. 
10 mM to chase the radioactive methionine. The Ii chain was 
immunoprecipitated, digested with Staphylococcus aureus V8 
protease, and characterized by SDS PAGE and autoradiog- 
raphy. The amount of label in fragments A, B, and C was 
then determined by densitometry of the autoradiograph (Fig. 
3). It can be predicted that label in a polypeptide fragment 
located close to the NH2-terminal end will remain constant, 
whereas label in fragments located close to the COOH-ter- 
minal end will increase with ime of the pulse. As can be seen 
in Fig. 3, the label in fragment C remains constant while label 
in fragments A and B increases with the length of the pulse. 
This clearly demonstrates that fragment C is located close to 
the NH2-terminal end of Ii chain. 
To demonstrate hat the C fragment from in vivo synthe- 
sized Ii chain is also recognized by In-1 antibody, we charac- 
terized Ii chain and its fragments by immunoblotting with In- 
1 antibody. Total protein from CH 1.1. cells either before or 
after digestion with Staphylococcus aureus V8 protease was 
separated by SDS PAGE, blotted onto nitrocellulose filter, 
and developed with In-I antibody. Fig. 4 shows that Ii chain 
and the 41-kD protein are recognized by In-1 antibody (lane 
1) as well as after V8 protease digestion the 10-kD fragment 
C (lane 2). Thus, we conclude that also in vivo the NH2- 
terminal fragment ofl i  chain carries the determinant required 
for the binding to In-1 antibody. 
To locate the first cleavage site in Ii chain, which removes 
a segment of ~ 1 kD (see Fig. 2, lane 2), membrane-inserted 
Ii chain was digested with Staphylococcus aureus V8 protease 
on intact microsomes and then immunoprecipitated. As no 
molecular weight shift could be detected under these condi- 
tions, it can be concluded that all cleavage sites for V8 protease 
must be located on the lumenal side (data not shown). 
Figure 4. In-I antibody recognizes proteolytic 
fragment C of li chain synthesized by CHI.I. 
cells. 1 x l0  7 mouse CHI.1. cells were detergent 
solubilized and nuclei removed bycentrifugation 
at 5,000 g for 10 min. Solubilized antigens were 
treated either with no protease (lane 1) or with 5 
/~g/ml ( ane 2) or 50 #g/ml (lane 3) V8 protease 
for 15 min at 30"C and then precipitated with 
10% TCA, 50% acetone. After resolubilization 
in SDS-containing sample buffer, proteins were 
separated by SDS PAGE. After transfer onto 
nitrocellulose, proteins were reacted with In-I 
antibody and visualized by peroxidase-coupled 
anti-rat antibody and diaminobenzidine stain- 
ing. 
Figure 5. Ii chain is synthesized 
without a cleavable signal sequence. 
Mouse CH 1.1. cells were labeled for 
1 h with [35S]methionine  the ab- 
sence (lane 1) or presence (lane 2) of 
3 ~g/ml tunicamycin (added 150 
min before labeling), mRNA from 
mouse spleen cells was translated in 
a wheat germ cell free system (lane 
3). Antigens were precipitated with 
In-I antibody, li, glycosylated Ii 
chain, li', unglycosylated Ii chain 
integrated (lane 2) or not integrated 
(lane 3) into membranes of the ER. 
M, molecular weight markers. 
l i  Chain Is Synthesized without a Cleavable 
Signal Sequence 
Membrane proteins which expose the NH2 terminus on the 
lumenal side of the ER are usually synthesized with a cleavable 
signal sequence (35, 51). In contrast, proteins that expose the 
NH2-terminal end on the cytoplasmic side, like the influenza 
neuraminidase and the rat and human asialoglycoprotein 
receptor, are synthesized without a cleavable signal sequence 
(15, 20, 41). We therefore asked whether Ii chain is also 
synthesized without a cleavable signal sequence. In glycopro- 
teins, the presence or absence or a cleavable signal sequence 
can be determined by comparing the molecular weight of the 
translation products ynthesized in a cell free system in the 
absence of microsomal membranes with those synthesized in
vivo in the presence of tunicamycin. Tunicamycin is known 
to prevent glycosylation but does not interfere with membrane 
insertion and cleavage of a signal sequence. As can be seen in 
Fig. 5, Ii chain is synthesized in CH 1.1. cells in the presence 
of tunicamycin as a 25-kD polypeptide chain. The identical 
molecular weight is found for the Ii chain when it is synthe- 
sized in a wheat germ cell free system in the absence of 
microsomal membranes. 
Membrane Insertion of  l i  Chain Is SRP Dependent 
For proteins that are translocated across the membrane of the 
ER, it is known that SRP and DP are required for their 
The Journal of Cell Biology, Volume 102, 1986 2172 
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Figure 6. SRP-dependent insertion of Ii 
chain into microsomal membranes. Spleen 
cell mRNA was translated in the wheat 
germ cell free system and synchronized 
after 5 min by 7-methyl-guanosine (lane 1). 
Translation was supplemented with salt- 
washed microsomal membranes (RMx) 
(lane 2) or SRP (lanes 3 and 4). In lane 4, 
RMK were added after 15 min of synthesis 
in the presence of SRP. 
insertion into the membrane (33, 42). For one membrane 
protein, which is synthesized without cleavable signal se- 
quence, it has been found that SRP and DP are required for 
membrane insertion but no arrest in elongation was observed 
(2). As demonstrated above, Ii chain is synthesized without a 
cleavable signal sequence, spans the membrane, and exposes 
the NH2 terminus on the cytoplasmic side. We tested therefore 
whether this type of protein requires SRP and DP for mem- 
brane insertion and whether elongation could be arrested by 
SRP. When Ii chain was translated in a wheat germ cell free 
translation system, the 25-kD unglycosylated form ofl i  chain 
was synthesized (Fig. 6, lane 1). When salt-washed rough 
microsomes, depleted of SRP, were added, no shift of molec- 
ular weight could be detected (Fig. 6, lane 2). When SRP 
alone was added to the cell free translation system, synthesis 
of Ii chain was arrested as well as that of heavy chain of IgG 
(Fig. 6, lane 3). The arrest in translation could be released 
when salt-washed rough microsomes (RMk) were added 15 
min after initiation of translation (Fig. 6, lane 4). Glycosylated 
Ii chains now accumulated. 
amino acid residues in the Ii chain. The remaining 170 amino 
acids are protected by the membrane barrier and must thus 
be located on the lumenal side of the membrane. (c) The 
monoclonal antibody In-1 recognizes a determinant located 
on a part of the Ii chain that is exposed on the cytoplasmic 
side of the membrane. Protease digestion of intact microsomal 
vesicles destroys this binding site. It is the NH2 terminally 
located fragment C which is recognized by In-l antibody. 
Two independent methods were used to locate fragment C 
within Ii chain: (i) After digestion of Ii chain with Staphylo- 
coccus aureus V8 protease, fragment C was found to be the 
only one that labeled with [3SS]cysteine. The only cysteine in 
Ii chain occurs 28 amino acid residues away from the NHE- 
terminal end (see Fig. 7). (ii) When a gradient of [3SS]cysteine 
label was introduced into Ii chain, the amount of label in 
fragment C remained constant hroughout the chase period. 
This is only consistent with a location of fragment C close to 
NHE-terminal end. (d) There is no cleavable signal sequence 
found in Ii chain. The unglycosylated precursor of Ii chain 
synthesized in the wheat germ cell free system in the absence 
of microsomal membranes has the identical molecular weight 
as unglycosylated and membrane-inserted Ii chain synthesized 
by CHI.1 cells. Cleavable signal sequences have a length 
between 13 and 45 amino acid residues (45). A difference of 
five amino acids would have been detected by the SDS PAGE 
system used. 
These facts demonstrate that Ii chain exposes the NHE- 
terminal end on the cytoplasmic and the COOH-terminal end 
on the lumenal side of the membrane of the ER. 
In-1 antibody has previously been used to locate the Ii 
chain on the cell surface (26). As this antibody, however, does 
not recognize a determinant exposed on the external surface 
of the cell, it must be concluded that broken cells were 
responsible for the observed binding of In- l antibody. Using 
fluorescence activated cell sorter analysis, no surface labeling 
could be detected using this antibody (Arnold, B., and J. Lipp, 
unpublished results). 
Discussion 
Orientation of  l i  across the ER Membrane C00H 
Several lines of evidence suggest hat Ii chain spans the V8---~] 
membrane and exposes the NH2-terminal end on the cyto- 
plasmic and the COOH-terminal end on the lumenal side of 
the membrane of the ER. (a) Sequence data derived from a 
cDNA for Ii chain locate a single stretch of 26 hydrophobic 
or uncharged amino acid residues close to the NH2-terminal >-~ [-" A 
end (1 l, 31, 42). Hydrophobic sequences are known to occur 
4 in regions of proteins that span the membrane. (b) When V8 protease is used to digest he cytoplasmically exposed portion MEMBRANE I I  
of li chain, a segment comprising -30  amino acid residues I L r  
can be removed. This segment corresponds to the length CYTOPLASM [[-cys .~[ 
found between the NH2 terminus and the stretch of uncharged - NH2 
Membrane Insertion o f  l i  Chain, a Type H 
Membrane-spanning Protein 
Proteins that span the membrane once can expose ither their 
COOH-terminal end (type 1 membrane proteins) or their 
NH2-terminal end (type 2 membrane proteins) on the cyto- 
plasmic side. Like secretory proteins, type 1 membrane pro- 
teins are usually synthesized with cleavable signal sequences. 
Their membrane insertion proceeds co-translationally and 
requires SRP and DP. The same requirements were found for 
B 
'C 
Figure 7. Schematic represen- 
tation ofli chain, li chain spans 
the ER membrane and exposes 
the NH2-terminal end on the 
cytoplasmic side and the 
COOH-terminal end on the lu- 
menal side. Proposed locations 
of cleavage sites for Staphylo- 
coccus aureus V8 protease and 
the fragments A, B and C are 
indicated. In-I antibody rec- 
ognizes that part of fragment C 
that is exposed on the cyto- 
plasmic side. 
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membrane insertion ofl i  chain for a typical type 2 membrane 
protein. 
What mechanism can be envisaged for a common step in 
membrane insertion of secretory and type 1 and 2 membrane 
proteins? A very attractive possibility, first proposed by Inouye 
and his colleagues for the lipoprotein of Escherichia coli and 
further extended to membrane-spanning proteins, is that the 
insertion of the NH2-terminal portion of nascent secretory or 
membrane-spanning proteins into the membrane of the ER 
occurs in a loop-like fashion (14, 22, 45). This model is based 
on the assumption that the NHE-terminal end of the signal 
sequence, cleavable or noncleavable, remains exposed on the 
cytoplasmic side of the ER membrane. Cleavage of the signal 
sequence then releases the new NH2-terminal end of the 
mature protein to the lumen of the ER vesicle. The cleaved 
signal sequence might remain in some or all cases buried in 
the membrane. Type l membrane-spanning proteins, like the 
H-2 antigens or VSV G protein, have in addition to a cleavable 
signal sequence a second stretch of uncharged amino acid 
residues located close to the COOH-terminal end. This func- 
tions as a "stop transfer" sequence and anchors the protein in 
the membrane. In type 2 membrane proteins with uncleaved 
signal sequence the single hydrophobic segment might per- 
form two functions: (a) as a single sequence mediating SRP- 
dependent membrane insertion, and (b) as a stop transfer 
sequence anchoring the protein in the membrane. Certainly 
further direct evidence is required for support of this model 
for membrane insertion of type 2 membrane proteins. 
We thank David I. Meyer and Christian Zwieb for helpful discussion 
and comments. We also thank Annie Steiner for typing this manu- 
script. 
This work was supported by a grant from the Deutsche Forschungs- 
gemeinschaft. 
Received for publication 5 December 1985, and in revised form 27 
February 1986. 
References 
I. Anderson, D. J., P. Walter, and G. Blobel. 1982. Signal recognition 
protein is required for theintegration of acetylcholine receptor subunit, a 
transmembrane giycoprotein, into the endoplasmic reticulum membrane. J. 
Cell Biol. 93:501-506. 
2. Anderson, D. J., K. E Mostov, and G. Blobel. 1983. Mechanisms of 
integration of de novo-synthesized polypeptides into membranes: signal recog- 
nition particle is required for integration into microsomal embranes of
calcium ATPase and of lens MP26 but not ofcytochrome bs. Proc. Natl. Acad. 
Sci. USA. 80:7249-7253. 
3. Blobel, G., and B. Dobberstein. 1975. Transfer of proteins across mem- 
branes. I. Presence of proteolytically processed and unprocessed nascent im- 
munoglobulin light chains o  membrane-bound ribosomes of murine mye- 
loma. J. Cell Biol. 67:835-851. 
4. Blobel, G. 1980. Intracellular protein topogenesis. Proc. Natl. Acad Sci. 
USA. 77:1496-1500. 
5. Bonatti, S., and G. Blobel. 1979. Absence of a cleavable signal sequence 
in Sindbis virus glycoprotein PE2. J. Biol. Chem. 254:12261-12264. 
6. Bonatti, S., G. Migliaccio, G. Blobel, and P. Walter. 1984. Role of signal 
recognition particle in themembrane assembly of Sindbis viral glycoproteins. 
Eur..L Biochem. 140:499-502. 
7. Bonner, W. M., and R. A. Laskey. 1974. A film detection method for 
tritium-labeled proteins a d nuclei acids in polyacrylamide gels. Eur. J. 
Biochem. 46:83-88. 
8. Bos, T. J., A. R. Davis, and D. P. Nayak. 1984. NH2-terminal hydro- 
phobic region ofinfluenza virus neuraminidase provides the signal function i
translocafion. Proc. Natl. Acad Sci. USA. 81:2327-2331. 
9. Chiacchia, K. B., and K. Drickamer. 1984. Direct evidence for the 
transmembrane ori ntation of the hepatic glycoprotein receptors. J. Biol Chem. 
259:15440-15446. 
10. Chirgwin, J. M., A. E. Prybyla, R. J. McDonald, and W. J. Rutter. 1979. 
Isolation of biologically active ribonuclei acid from sources enriched in ribo- 
nuclease. Biochemistry. 18:5294-5299. 
11. Claesson, L., D. Larhammer, L. Rask, and P. A. Peterson. 1983. cDNA 
clone for the human invariant chain ofclass 1I histocompatibility antigens and 
its implications for the protein structure. P oc. Natl. Acad Sci. USA. 80:7395- 
7399. 
12. Dobberstein, B., H. Garoff, G. Warren, and P. J. Robinson. 1979. Cell 
free synthesis and membrane insertion of mouse H-2D a histocompatibility 
antigen and/~2-immunoglobulin. Cell. 17:759-769. 
13. Dobberstein, B., J. Lipp, W. Lauer, and P. Singer. 1983. Biosynthesis 
and intracellular t ansport of Ia antigens. In Protein Synthesis. K. Abraham, 
T. S. Eikhom, and J. F. Pryme, editors. Humana Press, Inc., Clifton, NJ. 131- 
142. 
14. Engelman, D. M., and T. A. Steitz. 1981. The spontaneous insertion of 
proteins into and across membranes: the helical hairpin hypothesis. Cell. 
23:411--422. 
15. Fields, S., G. Winter, and G. G. Brownlee. 1981. Structure of the 
neuraminidase gene in human influenza virus A/PR/8/34. Nature (Lond.). 
290:213-217. 
16. Garoff, H., K. Simons, and B. Dobberstein. 1978. Assembly of Semliki 
Forest virus membrane glycoprotein in the membrane of the endoplasmic 
reticulum in vitro. J. Mot. Biol. 124:587-600. 
17. Garoff, H., A. M. Frisehauf, K. Simons, H. Lehrach, and H. Delius. 
1980. Nucleotide sequence of cDNA coding for Semliki Forest virus membrane 
glycoproteins. Nature (Lond.). 288:236-241. 
18. Gilmore, R., G. Blobel, and P. Walter. 1982. Protein translocation across 
the endoplasmic reticulum, i. Detection in the microsomal membrane of a 
receptor for the signal recognition particle. J. Cell Biol. 95:463--469. 
19. Gilmore, R., G. Blobel, and P. Walter. 1982. Protein translocation across 
the endoplasmic reticulum. II. Isolation and characterization f the signal 
recognition particle. 3". Cell Biol. 95:470-477. 
20. Holland, E. C., J. O. Leung, and K. Drickamer. 1984. Rat liver asialo- 
glycoprotein receptor lacks a cleavable NH: terminal signal sequence. Proc
Natl. Acad. Sci. USA. 81:7338-7342. 
21. Hortseh, M., and D. I. Meyer. 1984. Pushing the signal hypothesis: what 
are the limits? Biol. Cell. 52:1-8. 
22. Inouye, S., S. Wang, J. Sekizawa, S. Halegoua, and M. Inouye. 1977. 
Amino acid sequence for the peptide extension on the prolipoprotein of the 
Escherichia coli outer membrane. Proc. Natl. Acad. Sci. USA. 74:1004--1008. 
23. Jones, P. P., D. B. Murphy, D. Hewgill, and M. O. McDevitt. 1978. 
Detection of a common polypeptide chain in I-A and I-E subregion immuno- 
precipitates. Immunoeytoehemistry. 16:51-60. 
24. Katz, F. N., J. E. Rothman, V. R. Lingappa, G. Blobel, and H. F. Lodish. 
1977. Membrane assembly in vitro: synthesis giycosytation and asymmetric 
insertion of a transmembrane protein. Proc. Natl. Acad. Sei. USA. 74:3278- 
3282. 
25. Koch, N., and G. H~immerling. 1982. Structure ofla antigens: identifi- 
cation of dimeric complexes formed by the invariant chain. J. Immunol. 
128:1155-1158. 
26. Koch, N., S. Koch, and G. H/immerling. 1982. la invariant chain 
detected on lymphocyte surfaces by monoclonal antibody. Nature (Lond.). 
299:644-645. 
27. Kvist, S., K. Wiman, L. Claesson, P. A. Peterson, and B. Dobberstein. 
1982. Membrane insertion and oligomeric assembly of HLA-DR histocompat- 
ibility antigens. Cell. 29:61-69. 
28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assem- 
bly of the head of bacteriophage T4. Nature (Lond.). 227:680-685. 
29. Lee, J. S., J. Trowsdale, P. J. Travers, J. Carey, F. Grosveld, J. Jenkins, 
and W. F. Bodmer. 1982. Sequence of an HLA-DR a-chain cDNA clone and 
intron-exon orgainzation of the corresponding gene. Nature (Lond.) 299:750- 
752. 
30. Lingappa, V. R., F. N. Katz, H. F. Lodish, and G. Blobel. 1978. A signal 
sequence for the insertion of a transmembrane glycoprotein. Similarities to the 
signals of secretory proteins in primary structure and f nction. Z Biol. Chem. 
253:8667-8670. 
31. Long, E. O. 1985. In search of a function for the li chain associated with 
la antigens. Surv. Immunol. Res. 4:27-34. 
32. Meyer, D. I., and B. Dobberstein. 1980. Identification nd characteri- 
zation of a membrane component essential for the translocation of nascent 
secretory proteins across the membrane ofthe endoplasmic reticulum. J. Cell 
Biol. 87:503-508. 
33. Meyer, D. i., E. Krause, and B. Dobberstein. 1982. Secretory protein 
translocation across membranes--the role of the "docking protein". Nature 
(Lond.). 297:647-650. 
34. Moosic, J, P., A. Nilson, G. J. H~immerling, andD. J. McKean. 1980. 
Biochemical characterization of Ia antigens. Z Immunol. 125:1463-1469. 
35. Rapoport, T. A., and M. Wiedmann. 1985. Application of the signal 
hypothesis to the incorporation of integral membrane proteins. In Current 
Topics in Membranes and Transport. Vol. 24. F. Bronner, editor. Academic 
Press, Inc. New York 24:1-63. 
36. Roberts, B. E., and B. M. Paterson. 1973. Efficient translation f Tobacco 
Mosaic virus RNA and rabbit globin 9S RNA in a cell-free system from 
commercial wheat germ. P oc. Natl. Acad. Sci. USA. 70:2330-2334. 
37. Rothman, E. J., and H. F. Lodish. 1977. Synchronized transmembrane 
insertion and glycosylation of a nascent membrane protein. Nature (Lond.). 
269:775-780. 
The Journal of Cell Biology, Volume 102, 1986 2174 
 o
n
 January 9, 2006 
w
w
w
.jcb.org
D
ow
nloaded from
 
38. Rottier, P., J. Armstrong, and D. I. Meyer. 1985. Signal recognition 
particle-dependent insertion of coronavirus El, an intracellular membrane 
glycoprotein. J. Biol. Chem. 260:4648--4652. 
39. Schneider, C., H. J. Owen, D. Banville, and J. G. Williams. 1984. 
Primary structure of human transferrin receptor deduced from the mRNA 
sequence. Nature(Lond.). 311:675-678. 
40. Singer, P. A., W. Lauer, Z. Dembic, W. E. Mayer, J. Lipp, N. Koch, G. 
H~immerling, J. Klein, and B. Dobberstein. 1984. Structure of the murine la- 
associated irtvariant (Ii) chain as deduced from a eDNA clone. EMBO (Eur. 
Mol. BioL Organ.) J. 3:873-877. 
41. Spiess, M., A. L. Schwartz, and H. F. Lodish. 1985. Sequence of human 
asialoglycoprotein receptor eDNA. An internal signal sequence for membrane 
insertion. J Biol. Chem. 260:1979-1982. 
42. Strubin, M., B. Mach, and E. O. Long. 1984. The complete sequence of
the mRNA for the HLA-DR associated li chain reveals a polypeptide with an 
unusual transmembrane polarity. EMBO (Eur. Mot. Biol. Organ.) J. 3:869- 
872. 
43. Sung, E., and P. Jones. 198 I. The invariant chain of murine Ia antigens: 
its glycosylation, abundance and subcellular locaiisation. Mot. Immunol. 
18:899-913. 
44. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer 
of proteins from polyacrylamide g ls to nitrocellulose sheets: procedure and 
some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354. 
45. Von Heijne, G. 1985. Structural and thermodynamic aspects of the 
transfer of proteins into and across membranes. In Current Topics in Mere- 
branes and Transport. Vol 24. F. Bronner, editor. Academic Press, lnc., New 
York. 1-63. 
46. Waiter, P., I. lbrahimi, and G. Blobel. 1981. Translocation of proteins 
across the endoplasmic reticulum. I. Signal recognition prolein (SRP) binds to 
in vitro-assembled polysomes ynthesizing secretory protein. J. Cell Biol. 
91:545-550. 
47. Waiter, P., and G. Blobel. 1981. Translocation of proteins across the 
endoplasmic reticulum. II. Signai recognition protein (SRP) causes ignal 
sequence-dependent and site-specific arrest of chain elongation that is released 
by microsomal membranes. J. Cell Biol. 91:557-561. 
48. Waiter, P., and G. Blobel. 1980. Purification of a membrane-associated 
protein complex required for protien translocation across the endoplasmic 
reticulum. Proc. Natl. Acad. Sci. USA. 77:7112-7116. 
49. Walter, P., and G. Blobel. 1982. Signal recognition particle contains a
7S RNA essential for protein translocation across the endoplasmic reticulum. 
Nature (Lond. ). 299:691-698. 
50. Walter, P., R. Gilmore, and G. Blobel. 1984. Protein translocation across 
the endoplasmic reticulum Cell. 38:5-8. 
51. Wickner, W. T., and H. F. Lodish. 1985. Multiple mechanisms of protein 
insertion into and across membranes. Science (Wash. DC). 230:400--407. 
52. Yamamoto, K., N. Koch, M. Steinmetz, and G. J. H~immerling. 1985. 
One gene encodes two distinct In-associated li chains. J. Immunol. 134:3461- 
3467. 
53. Zecher, R., W. Bailhausen, K. Reske, D. Linder, M. Schliiter, and S. 
Stirn. 1984. lnvariant chains of mouse class II antigens: biochemical properties 
and molecular relationship. Eur. J. lmmunol. 14:511-517. 
Lipp and Dobberstein Membrane Junction of li Chain 2175 
 o
n
 January 9, 2006 
w
w
w
.jcb.org
D
ow
nloaded from
 
